CSIMarket
 


Renovorx Inc   (RNXT)
Other Ticker:  
 

Renovorx Inc 's Quick Ratio

RNXT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




RNXT Quick Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 76.32 % - - - -
Y / Y Cash & cash equivalent Change -54.22 % - - - -
Quick Ratio MRQ 7.36 9.59 9.33 16.2 28.36
Overall Ranking # # # # #
Seq. Current Liabilities Change -1.87 % -20.13 % 49.89 % 50.08 % -
Seq. Cash & cash equivalent Change -24.63 % -17.96 % -13.63 % -14.29 % -



Quick Ratio third quarter 2022 Comment
Regardless of the sequential decrease in Current Liabilities, Quick Ratio detoriated to 7.36 above company average Quick Ratio.

Within Major Pharmaceutical Preparations industry Renovorx Inc booked the highest Quick Ratio than Renovorx Inc in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are RNXT Segments?
See Quick Ratio RNXT on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Renovorx Inc 's Current Liabilities $ 1 Millions Visit RNXT's Balance sheet
Renovorx Inc 's Cash & cash equivalent $ 8 Millions Visit RNXT's Balance sheet
Source of RNXT's Sales Visit RNXT's Sales by Geography


Cumulative Renovorx Inc 's Quick Ratio

RNXT's Quick Ratio for the trailling 12 Months

RNXT Quick Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 76.32 % - - - -
Y / Y Cash & cash equivalent TTM Growth -54.22 % - - - -
Quick Ratio TTM 10.33 13.88 15.51 21.06 28.36
Total Ranking TTM # # 291 # 259 # #
Seq. Current Liabilities TTM Growth -1.87 % -20.13 % 49.89 % 50.08 % -
Seq. Cash & cash equivalent TTM Growth -24.63 % -17.96 % -13.63 % -14.29 % -


TTM Quick Ratio Comment
On the trailing twelve months basis Due to decrease in Current Liabilities in the III. Quarter to $1.10 millions, average cumulative Quick Ratio decreased to 10.33 below the Renovorx Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry RNXT achieved the highest Quick Ratio. While Quick Ratio overall ranking has improved so far to 0, from total ranking in previous quarter at 286.

Explain Quick Ratio?
What are RNXT Segments?
See Quick Ratio RNXT on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market # 0


TTM Quick Ratio Statistics
High Average Low
15.67 14.78 13.88
(Mar 31 2022)   (Jun 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Forte Biosciences Inc   19.21 $ 44.048  Millions$ 2.293  Millions
Kura Oncology Inc   19.06 $ 427.775  Millions$ 22.441  Millions
Lantern Pharma Inc   18.98 $ 57.827  Millions$ 3.047  Millions
Verve Therapeutics Inc   18.98 $ 550.710  Millions$ 29.018  Millions
Nuvalent Inc   18.50 $ 240.064  Millions$ 12.975  Millions
Minerva Neurosciences Inc   18.31 $ 40.220  Millions$ 2.197  Millions
Agios Pharmaceuticals Inc   18.11 $ 727.680  Millions$ 40.171  Millions
Astria Therapeutics inc   18.10 $ 116.571  Millions$ 6.441  Millions
Olema Pharmaceuticals inc   17.73 $ 222.600  Millions$ 12.552  Millions
Point Biopharma Global Inc   17.55 $ 291.519  Millions$ 16.608  Millions
Generation Bio Co   17.39 $ 301.169  Millions$ 17.318  Millions
Pardes Biosciences Inc   17.38 $ 209.055  Millions$ 12.028  Millions
Annovis Bio inc   17.33 $ 31.987  Millions$ 1.846  Millions
Stoke Therapeutics Inc   17.06 $ 251.655  Millions$ 14.749  Millions
Immuneering Corp  16.87 $ 117.197  Millions$ 6.947  Millions
Syndax Pharmaceuticals Inc   16.86 $ 350.708  Millions$ 20.803  Millions
Moonlake Immunotherapeutics  16.82 $ 83.459  Millions$ 4.962  Millions
Akouos inc   16.79 $ 169.328  Millions$ 10.087  Millions
Kinnate Biopharma Inc   16.78 $ 257.448  Millions$ 15.343  Millions
Zomedica Corp   16.74 $ 119.295  Millions$ 7.126  Millions
Cerevel Therapeutics Holdings Inc   16.49 $ 989.918  Millions$ 60.020  Millions
Adicet Bio Inc   16.41 $ 282.679  Millions$ 17.221  Millions
Rapt Therapeutics Inc   15.87 $ 195.436  Millions$ 12.316  Millions
Fulcrum Therapeutics Inc   15.09 $ 221.789  Millions$ 14.699  Millions
Crinetics Pharmaceuticals Inc   15.00 $ 368.362  Millions$ 24.556  Millions
Nkarta Inc   14.85 $ 392.356  Millions$ 26.425  Millions
Akero Therapeutics Inc   14.82 $ 374.003  Millions$ 25.243  Millions
Pds Biotechnology Corp  14.80 $ 71.642  Millions$ 4.841  Millions
Oric Pharmaceuticals Inc   14.58 $ 193.659  Millions$ 13.284  Millions
Cytokinetics Incorporated  14.36 $ 867.664  Millions$ 60.440  Millions

Date modified: 2022-11-27T22:37:56+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GRVY's Profile

Stock Price

GRVY's Financials

Business Description

Fundamentals

Charts & Quotes

GRVY's News

Suppliers

GRVY's Competitors

Customers & Markets

Economic Indicators

GRVY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071